Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study

Primary sclerosing cholangitis (PSC) is a chronic cholestatic disease with no approved treatments. C‐C chemokine receptor types 2 and 5 (CCR2/CCR5) play an important role in inflammation and fibrosis and are potential therapeutic targets for PSC. We evaluated the efficacy and safety of cenicriviroc...

Descripción completa

Detalles Bibliográficos
Autores principales: Eksteen, Bertus, Bowlus, Christopher L., Montano‐Loza, Aldo J., Lefebvre, Eric, Fischer, Laurent, Vig, Pamela, Martins, Eduardo Bruno, Ahmad, Jawad, Yimam, Kidist K., Pockros, Paul J., Feld, Jordan J., Minuk, Gerald, Levy, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917279/
https://www.ncbi.nlm.nih.gov/pubmed/33681680
http://dx.doi.org/10.1002/hep4.1619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917279/
https://www.ncbi.nlm.nih.gov/pubmed/33681680
http://dx.doi.org/10.1002/hep4.1619

Ejemplares similares